On Friday, Organogenesis Holdings Inc (NASDAQ: ORGO) was -12.39% drop from the session before, before settling in for the closing price of $4.68. A 52-week range for ORGO has been $2.61 – $6.71.
When this article was written, the company’s average yearly earnings per share was at 207.50%. With a float of $59.16 million, this company’s outstanding shares have now reached $126.85 million.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Organogenesis Holdings Inc stocks. The insider ownership of Organogenesis Holdings Inc is 53.37%, while institutional ownership is 54.86%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.1 earnings per share (EPS) during the time that was better than consensus figure (set at 0.02) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 207.50% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
You can see what Organogenesis Holdings Inc (ORGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.34 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Compared to the last year’s volume of 1.36 million, its volume of 1.23 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 39.16%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 50.68%, which indicates a significant increase from 13.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.75, while its 200-day Moving Average is $4.08. Nevertheless, the first resistance level for the watch stands at $4.54 in the near term. At $4.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.27. If the price goes on to break the first support level at $3.80, it is likely to go to the next support level at $3.51. Now, if the price goes above the second support level, the third support stands at $3.07.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are 126,858K outstanding shares of the company, which has a market capitalization of 520.12 million. As of now, sales total 482,040 K while income totals 860 K. Its latest quarter income was 101,010 K while its last quarter net income were -9,390 K.
